Smart Adaptive Artificial Channels Triggered by Hypoxia for Highly Selective Apoptosis in Cancer Cells

Q Qiuping Zhang X Xiaopan Xie (State Key Laboratory of Vaccines for Infectious Diseases Xiang An Biomedicine Laboratory Fujian Provincial Key Laboratory of Innovative Drug Target Research MOE Key Laboratory of Spectrochemical Analysis and Instrumentation School of Pharmaceutical Sciences Xiamen University Xiamen Fujian China) Q Qinghong Liang (Fujian Provincial Key Laboratory of Innovative Drug Target Research State Key Laboratory of Vaccines for Infectious Diseases Xiang An Biomedicine Laboratory MOE Key Laboratory of Spectrochemical Analysis and Instrumentation School of Pharmaceutical Sciences Xiamen University Xiamen Fujian 361102 China) N Nan Sheng T Ting Lin (Beijing National Center for Electron Microscopy and Laboratory of Advanced Materials, School of Materials Science and Engineering) C Changliang Ren (State Key Laboratory of Vaccines for Infectious Diseases Xiang An Biomedicine Laboratory Fujian Provincial Key Laboratory of Innovative Drug Target Research MOE Key Laboratory of Spectrochemical Analysis and Instrumentation School of Pharmaceutical Sciences Xiamen University Xiamen Fujian China)

Abstract

Abstract In nature, hypoxia‐sensitive ion channels regulate the ion transport in response to oxygen levels, which are critical for cellular adaptation to low‐oxygen environments. However, this intriguing stimuli‐responsive property has yet to be replicated in artificial ion channels designed to mimic the essential functions of their natural counterparts. Herein, we introduce a novel class of adaptive artificial channels activatable under hypoxic conditions in cancer cells. Reductase‐mediated reduction of nitro and/or azo groups triggers the rapid release of channel‐forming units, which dimerize into chloride channels or further assemble into nanopores of varying cavity sizes at high concentrations in the presence of cholesterol. Upon activation, the most sensitive channel, C1 , demonstrates an 18.1‐fold enhancement in cytotoxicity against HepG2 cells with an IC 50 of 2.9 µM. Remarkably, C1 exhibits exceptional selectivity for liver cancer cells over normal liver cells, with a selectivity index of 17.9, surpassing that of doxorubicin by 44.8 folds while maintaining comparable anticancer efficacy.

Article Details

Volume / Issue Vol. 64, Issue 51
Published December 15, 2025
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (6)

Q

Qiuping Zhang

X

Xiaopan Xie

State Key Laboratory of Vaccines for Infectious Diseases Xiang An Biomedicine Laboratory Fujian Provincial Key Laboratory of Innovative Drug Target Research MOE Key Laboratory of Spectrochemical Analysis and Instrumentation School of Pharmaceutical Sciences Xiamen University Xiamen Fujian China

Q

Qinghong Liang

Fujian Provincial Key Laboratory of Innovative Drug Target Research State Key Laboratory of Vaccines for Infectious Diseases Xiang An Biomedicine Laboratory MOE Key Laboratory of Spectrochemical Analysis and Instrumentation School of Pharmaceutical Sciences Xiamen University Xiamen Fujian 361102 China

N

Nan Sheng

T

Ting Lin

Beijing National Center for Electron Microscopy and Laboratory of Advanced Materials, School of Materials Science and Engineering

C

Changliang Ren

State Key Laboratory of Vaccines for Infectious Diseases Xiang An Biomedicine Laboratory Fujian Provincial Key Laboratory of Innovative Drug Target Research MOE Key Laboratory of Spectrochemical Analysis and Instrumentation School of Pharmaceutical Sciences Xiamen University Xiamen Fujian China